Analystreport

Spero Therapeutics Inc (NASDAQ: SPRO) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating on the stock.

Spero Therapeutics, Inc.  (SPRO) 
Last spero therapeutics, inc. earnings: 3/16 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: investors.sperotherapeutics.com/overview